|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM361024711 |
003 |
DE-627 |
005 |
20240822232411.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2023 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.3c01270
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1509.xml
|
035 |
|
|
|a (DE-627)NLM361024711
|
035 |
|
|
|a (NLM)37603854
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Lehman, Sean E
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Particle Metrology Approach to Understanding How Storage Conditions Affect Long-Term Liposome Stability
|
264 |
|
1 |
|c 2023
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 06.09.2023
|
500 |
|
|
|a Date Revised 22.08.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Lipid nanoparticles are a generic type of nanomaterial with broad applicability in medicine as drug delivery vehicles. Liposomes are a subtype of lipid nanoparticles and, as a therapeutic platform, can be loaded with a genetic material or pharmaceutical agents for use as drug treatments. An open question for these types of lipid nanoparticles is what factor(s) affect the long-term stability of the particles. The stability of the particle is of great interest to understand and predict the effective shelf-life and storage requirements. In this report, we detail a one-year study of liposome stability as a function of lipid composition, buffer composition/pH, and storage temperature. This was done in aqueous solution without freezing. The effect of lipid composition is shown to be a critical factor when evaluating stability of the measured particle size and number concentration. Other factors (i.e., storage temperature and buffer pH/composition) were shown to be less critical but still have some effect. The stability of these particles informs formulation and optimal storage requirements and assists with future developmental planning of a NIST liposome-based reference material. This work also highlights the complex nature of long-term soft particle storage in biopharmaceutical applications
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Liposomes
|2 NLM
|
650 |
|
7 |
|a Biological Products
|2 NLM
|
650 |
|
7 |
|a Biotin
|2 NLM
|
650 |
|
7 |
|a 6SO6U10H04
|2 NLM
|
650 |
|
7 |
|a Lipids
|2 NLM
|
700 |
1 |
|
|a Benkstein, Kurt D
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cleveland, Thomas E
|c 4th
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Anderson, Kyle W
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Carrier, Michael J
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Vreeland, Wyatt N
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1999
|g 39(2023), 35 vom: 05. Sept., Seite 12313-12323
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:39
|g year:2023
|g number:35
|g day:05
|g month:09
|g pages:12313-12323
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.3c01270
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 39
|j 2023
|e 35
|b 05
|c 09
|h 12313-12323
|